Deutsche Bank’s Immunome IMNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.18M Sell
101,550
-10,043
-9% -$249K ﹤0.01% 1711
2026
Q2
$2.36M Buy
111,593
+22,456
+25% +$481K ﹤0.01% 1807
2026
Q1
$1.95M Buy
89,137
+12,895
+17% +$287K ﹤0.01% 1792
2025
Q4
$1.64M Buy
76,242
+15,291
+25% +$268K ﹤0.01% 1910
2025
Q3
$714K Buy
60,951
+7,209
+13% +$71.7K ﹤0.01% 2359
2025
Q2
$500K Sell
53,742
-9,940
-16% -$81.5K ﹤0.01% 2460
2025
Q1
$429K Buy
63,682
+17,607
+38% +$169K ﹤0.01% 2563
2024
Q4
$489K Buy
46,075
+15,514
+51% +$187K ﹤0.01% 2623
2024
Q3
$447K Buy
30,561
+8,535
+39% +$121K ﹤0.01% 2520
2024
Q2
$267K Buy
22,026
+21,574
+4,773% +$337K ﹤0.01% 2660
2024
Q1
$11.2K Buy
+452
New +$9.17K ﹤0.01% 3528
2021
Q2
– Sell
-1,340
Closed -$45K – 4692
2021
Q1
$45K Sell
1,340
-126
-9% -$3.13K ﹤0.01% 4259
2020
Q4
$14K Buy
+1,466
New +$17.1K ﹤0.01% 4277

Other funds holding IMNM

Deutsche Bank's IMNM Position: Q3 2026 in Review

Deutsche Bank reduced its Immunome (IMNM) stake by 9% in Q3 2026, selling an estimated $249K and leaving 101,550 shares worth $2.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1711.

Deutsche Bank first reported a position in IMNM in Q4 2020 and has held it in 13 quarters since. The position peaked at $2.36M in Q2 2026. 109 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.

  • Deutsche Bank held 101,550 shares of Immunome worth $2.18M as of Q3 2026.
  • Deutsche Bank sold 10,043 Immunome shares in Q3 2026, an estimated $249K.
  • Immunome made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #1711 holding.
  • Deutsche Bank first reported a position in Immunome in Q4 2020 and has held it in 13 quarters since.
  • Deutsche Bank's Immunome position peaked at $2.36M in Q2 2026.
  • 109 funds tracked by Wall St. Rank held Immunome as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.